Suppliers / Aaa Pharmaceuticals

Aaa Pharmaceuticals

United States Updated 9 July 2026

Aaa Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 10 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 March 2025 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 2 with an FDA FEI number
10
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 28 March 2025 VAI US FDA
  • 15 May 2024 VAI US FDA
  • 3 April 2019 VAI US FDA
  • 21 April 2016 NAI US FDA
  • 14 March 2014 VAI US FDA
  • 14 March 2014 NAI US FDA
  • 14 February 2013 NAI US FDA
  • 13 February 2013 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Paulsboro, United States 2246707
Lumberton, United States 3010027650

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 10 2

Comparing suppliers?

Choose your molecules and target markets. Aaa Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 28 March 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates